Pain

Articles

• 2017. Maiese BA et al. – Hospitalization costs for patients undergoing orthopedic surgery treated with intravenous acetaminophen (IV-APAP) plus other IV analgesics or IV opioid monotherapy for postoperative pain
• 2016. Karabis A et al. – High correlation of VAS pain scores after 2 and 6 weeks of treatment with VAS pain scores at 12 weeks in randomised controlled trials in rheumatoid arthritis and osteoarthritis: Meta-analysis and implications
• 2015. Nilsson J et al. – Burden of herpes zoster and post-herpetic neuralgia in Sweden
• 2014. Duracinsky M et al. – ARIZONA study: Is the risk of post-herpetic neuralgia and its burden increased in the most elderly patients?
• 2014. Zeppetella G et al. – A network meta-analysis of the efficacy of opioid analgesics for the management of breakthrough cancer pain episodes
• 2014. Baron R et al. – Refractory chronic pain screening tool (RCPST): A feasability study to assess practicability and validity of identifying potential neurostimulation candidates
• 2013. van Seventer R et al. – Validation of the Dutch version of the DN4 diagnostic questionnaire for neuropathic pain
• 2012. Humphrey L et al. – The bladder pain/interstitial cystitis symptom score: Development, validation, and identification of a cut score
• 2012. Ghosh S et al. – Epidemiology of HIV-related neuropathy: A systematic literature review
• 2011. Vissers DC et al. – An economic evaluation of short-acting opioids for treatment of breakthrough pain in patients with cancer
• 2010. Vissers D et al. – Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer
• 2010. Arnould B et al. – The impact of herpes zoster and subsequent chronic pain on patients’ daily lives
• 2008. Crawford B et al. – Conceptual adequacy of the neuropathic pain symptom inventory in six countries

Posters & Presentations

• 2016. ISPOR European Congress – Translation of the DN4 (Douleur Neuropathique en 4 Questions) into 85 languages: Challenges and Importance of the Conceptual Definition of the Original Version
• 2014. Biannual International Multidisciplinary Pain Congress – Comparative efficacy of non-steroidal anti-inflammatory drugs in pain relief: Results of a systematic literature review and network meta-analysis
• 2011. ISPOR European Congress – Burden of Herpes Zoster and Post-Herpetic Neuralgia: Findings from a Cross-Sectional Patient Reported Outcomes Study
• 2010. ISPOR European Congress – Impact of Herpes Zoster and Postherpectic Neuralgia on Patients’ Quality of Life
• 2010. ISPOR European Congress – Herpes Zoster and Post-Herpetic Neuralgia: Considerations for a Prospective, Cross-Sectional Patient-Reported Outcomes Study
• 2009. ISPOR Annual International Meeting – Patient-Reported Outcome (PRO) Labeling Claims in Pain Treatment: Overview of US and European Drug Approvals
• 2008. ISPOR European Congress – Budget Impact of the Use of OROS® Hydromorphone Once Daily in Severe Chronic Pain Patients in the German Health Care System
• 2008. ISPOR European Congress – Efficacy of Opioids in the Treatment of Breakthrough Cancer Pain: A Bayesian Mixed Treatment Comparison
• 2008. ISPOR European Congress – Assessing the Value of 24-Hour Chronic Pain Control from the Patient Perspective: Do Existing Patient-Reported Outcomes Instruments Adequately Cover the Relevant Concepts Related to 24-Hour Chronic Pain Control?
• 2008. ISPOR Annual International Meeting – Evaluation of the Neuropathic Pain Symptom Inventory: Conceptual Adequacy in Six Countries
• 2005. ISPOR European Congress – Development and Validation of a Comprehensive Painful Symptom Checklist Allowing to Provide a Complete Description of Pain in Ophthalmic Diseases